
Merck & Co. said its surprise decision Thursday to withdraw the
arthritis drug Vioxx -- used by about 2 million people worldwide --
was driven by recent evidence that the drug's adverse side effects
outweighed any potential benefits.
The following editorial appeared in Thursday's Washington Post:
The two Merck & Co. executives were somber as the
company plane pitched and rolled through the remnants of Hurricane
Jeanne on the night of Sept. 28.
Less than a week after Merck & Co. yanked its popular Vioxx
arthritis drug off the market, the New England Journal of Medicine
voiced strong concerns Wednesday about the safety of Pfizer's
bestselling Celebrex.